2014
DOI: 10.1016/j.tranon.2014.05.009
|View full text |Cite
|
Sign up to set email alerts
|

Claudin-1 Expression Is Elevated in Colorectal Cancer Precursor Lesions Harboring the BRAF V600E Mutation

Abstract: BACKGROUND: Sessile serrated adenomas/polyps (SSA/P) are now recognised precursors of colorectal cancer (CRC) including cancers harbouring somatic BRAF (V600E) mutations. While the morphological diagnostic criteria of SSA/P have been established, distinguishing between small/early SSA/P and microvesicular hyperplastic polyps (MVHP) is challenging and may not be possible in routine practice. METHODS: Gene expression profiling of MVHP (n=5, all BRAF V600E wild-type) and SSA/P (n=5, all BRAF V600E mutant) samples… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
13
1
1

Year Published

2016
2016
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 22 publications
(16 citation statements)
references
References 51 publications
1
13
1
1
Order By: Relevance
“…Eleven of 51 genes showed frequent overexpression in CIMP-H and/or MLH1 -silenced colon cancers including all seven that showed frequent increased expression in hypermutated cancers (Supplementary Table 3). We did not observe frequent increased expression of previous SSA/P markers (annexin A10 - ANXA10 and claudin 1 - CLDN1 ) in hypermutated, CIMP-H and/or MLH1 silenced colon cancers (Table 1 and Supplementary Table 3) (19, 31). …”
Section: Resultsmentioning
confidence: 56%
See 1 more Smart Citation
“…Eleven of 51 genes showed frequent overexpression in CIMP-H and/or MLH1 -silenced colon cancers including all seven that showed frequent increased expression in hypermutated cancers (Supplementary Table 3). We did not observe frequent increased expression of previous SSA/P markers (annexin A10 - ANXA10 and claudin 1 - CLDN1 ) in hypermutated, CIMP-H and/or MLH1 silenced colon cancers (Table 1 and Supplementary Table 3) (19, 31). …”
Section: Resultsmentioning
confidence: 56%
“…Using the cBioPortal we evaluated concurrent genomic alterations (RNA expression and somatic mutation) in each of our 51-gene panel and two genes from previous microarray studies ( ANXA10 and CLDN1 ) with alterations in BRAF (19, 31). Thirteen of 51 genes showed statistically significant associations with BRAF mutation both by Fisher exact test and log odds ratio (Supplementary Table 4).…”
Section: Resultsmentioning
confidence: 99%
“…The BRAF V600E mutation, specifically, has been hypothesized to be an early event in tumorigenesis . CLDN1 was found to be upregulated in polyps bearing the BRAF V600E somatic mutation, on both the gene expression and protein level . Another study that investigated immunohistochemical detection of CLDN18 in serrated pathway lesions found higher expression of this TJ protein in sessile‐serrated adenomas than in hyperplastic polyps or conventional adenomas .…”
Section: Discussionmentioning
confidence: 99%
“…Nominally, based on the frequency of detecting crypt branching, CSL without dilation of the basal portions of the crypts, CSL with doubtful dilation and with significant dilation of the basal portions of one crypt can be combined into one group, and CSL with dilation of the basal portions of two and more crypts and with horizontal growth of the basal portions of the crypts -into the other (Figure 4). 6. By the size, CSLs without dilation of the basal portions of the crypts and CSLs with doubtful dilation of the basal portions are significantly smaller than formations of the remaining groups, while CSLs with horizontal growth of the basal portions of the crypts are larger ( Figure 5).…”
Section: Morphological Characteristicsmentioning
confidence: 94%